Company

Antios Therapeutics

Rocket Ship Rating

Rocket Ship Rating: 95 out of 100

Innovative therapies to treat and cure hepatitis B virus (HBV) and other viral diseases

Also known as Antios Therapeutics, Inc

Biotech & therapeutics

Status: Operatingas of 2026-09-17
Business model: B2B
Legal name: Antios Therapeutics, Inc

Open relationship map

Claim, correct or request removal

Record updated 29 September 2026

Funding snapshot

Total raised: $126MSEC form D sum, as of 2026-09-29Source (opens in a new tab)
Latest round: Round, $75M2021-11-02

Funding rounds

Round, 2021: $75M2021-11-02, SEC form D sold, 35 investors
Round, 2021: $32M2021-04-09, SEC form D sold, 29 investors
Round, 2020: $4.4M2020-07-31, SEC form D sold, 9 investors
Round, 2018: $15M2018-11-20, SEC form D sold, 10 investors

Products

Other: ATI-2173